secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2024-03-11T23:59:59+00:00
Accession:  0001493152-24-009485
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric issues 228,690 shares for waiver of variable-rate limitation, enabling ATM facility
--------------------------------------------------------------------------------

- Issued 228,690 common shares at $1.41/share to institutional investors; no proceeds to Enveric.
- Investors permanently waive variable rate transaction limitation from Dec 28, 2023 inducement letters.
- Waiver allows Enveric to utilize its 'at the market' offering facility with Canaccord Genuity.
- Closing expected March 12, 2024; shares represent ~4.2% of outstanding (5.4M pre-offering).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315224009485/0001493152-24-009485-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315224009485/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-009485

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer